M&A Deal Summary

NaviMed Capital Acquires ClariMed

On January 1, 2022, private equity firm NaviMed Capital acquired medical products company ClariMed

Acquisition Highlights
  • This is NaviMed Capital’s 1st transaction in the Medical Products sector.
  • This is NaviMed Capital’s 3rd transaction in the United States.
  • This is NaviMed Capital’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2022-01-01
Target ClariMed
Sector Medical Products
Buyer(s) NaviMed Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

ClariMed

Chadds Ford, Pennsylvania, United States
ClariMed is a human-centered development and regulatory practice for medical products developed by Pharmaceutical and Medical device manufacturers. ClariMed is based in Chadds Ford, Pennsylvania.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

NaviMed Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2011
Size Small
Type Sector Focused
DESCRIPTION

NaviMed Capital is a private equity firm focused exclusively on investments in the healthcare sector. NaviMed seeks North American headquartered businesses with strong organic and inorganic opportunities for growth. The Firm will consider both control and minority positions looks to commit $5 to $30 million of equity capital per transaction. NaviMed Capital was established in 2011 and is based in Rosslyn, Virginia.

DEAL STATS #
Overall 3 of 4
Sector (Medical Products) 1 of 2
Type (Buyout (LBO, MBO, MBI)) 3 of 4
State (Pennsylvania) 1 of 2
Country (United States) 3 of 4
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-08 Velocity Clinical Research

Durham, North Carolina, United States

Velocity Clinical Research is an integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity Clinical Research was founded in 2017 and is based in Durham, North Carolina.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-28 CM Group

Hingham, Massachusetts, United States

CM Group is a provider of information and knowledge services to the biopharmaceutical community. The Group provides service offerings for the biopharmaceutical industry in four key areas, including Strategic Meeting Services, Congress Management, Patient Experience, and Speaker Bureau Management. CM Group is based in Hingham, Massachusetts.

Sell -
Mergr

Product

Company

Legal